Yi Liang Wei
Director/Board Member presso BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD.
Profilo
Yi Liang Wei is currently a Non-Executive Director at Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Previously, he held positions as Vice Chairman at Tianjin Motimo Membrane Technology Co., Ltd., Director at Hanon Advanced Technology Group Co., Ltd., Director at Eucure Beijing Biopharma Co Ltd from 2016 to 2021, and Chief Investment Officer at China SDIC Gaoxin Industrial Investment Corp.
Ltd.
He also served as a Member-Supervisory Board at Jiangsu Shagang Co., Ltd.
from 2008 to 2014.
Dr. Wei obtained his undergraduate degree from Shaanxi University of Science & Technology in 1993 and his doctorate degree from Chinese Academy of Fiscal Sciences in 2009.
Posizioni attive di Yi Liang Wei
| Società | Posizione | Inizio |
|---|---|---|
| BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. | Director/Board Member | 12/11/2015 |
Precedenti posizioni note di Yi Liang Wei
| Società | Posizione | Fine |
|---|---|---|
| Eucure Beijing Biopharma Co Ltd | Director/Board Member | 01/08/2021 |
| JIANGSU SHAGANG CO., LTD. | Director/Board Member | - |
Hanon Advanced Technology Group Co., Ltd.
 Hanon Advanced Technology Group Co., Ltd. Medical SpecialtiesHealth Technology Hanon Advanced Technology Group Co., Ltd. develops and manufactures analysis instruments. The company produces nitrogen analyzer, fat analyzer, fiber analyzer, and more. It provides its products for food, pharmacy, agriculture, environment, third-party testing, and chemical fields. The company was founded on November 29, 2006 and is headquartered in Jinan, China. | Director/Board Member | - |
China SDIC Gaoxin Industrial Investment Corp. Ltd.
 China SDIC Gaoxin Industrial Investment Corp. Ltd. Investment ManagersFinance China SDIC Gaoxin Industrial Investment Corp. Ltd. engages in the operation of direct investment, and equity fund businesses. Its Direct Investment business operates as a holding company with interests in the following industries: advanced manufacturing and information technology, medicine, healthcare and life science, environmental protection, and new materials. Its Equity Fund business involves in the management of private equity funds. The company was founded in 1987 and is headquartered in Beijing, China. | Chief Investment Officer | - |
| TIANJIN MOTIMO MEMBRANE TECHNOLOGY CO.,LTD | Director/Board Member | - |
Formazione di Yi Liang Wei
| Shaanxi University of Science & Technology | Undergraduate Degree |
| Chinese Academy of Fiscal Sciences | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| JIANGSU SHAGANG CO., LTD. | Non-Energy Minerals |
| TIANJIN MOTIMO MEMBRANE TECHNOLOGY CO.,LTD | Producer Manufacturing |
| BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. | Commercial Services |
 | Health Technology |
| Aziende private | 2 |
|---|---|
China SDIC Gaoxin Industrial Investment Corp. Ltd.
China SDIC Gaoxin Industrial Investment Corp. Ltd. Investment ManagersFinance China SDIC Gaoxin Industrial Investment Corp. Ltd. engages in the operation of direct investment, and equity fund businesses. Its Direct Investment business operates as a holding company with interests in the following industries: advanced manufacturing and information technology, medicine, healthcare and life science, environmental protection, and new materials. Its Equity Fund business involves in the management of private equity funds. The company was founded in 1987 and is headquartered in Beijing, China. | Finance |
| Eucure Beijing Biopharma Co Ltd |
- Borsa valori
- Insiders
- Yi Liang Wei
